Turkish Validity and Reliability Study of Virtual Reality Sickness Questionnaire
1 other identifier
observational
100
1 country
1
Brief Summary
This study is planned for the cultural adaptation and validity of the "Virtual Reality Sickness Questionnaire".
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2020
CompletedFirst Posted
Study publicly available on registry
July 23, 2020
CompletedStudy Start
First participant enrolled
June 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedApril 18, 2023
April 1, 2023
1.6 years
July 20, 2020
April 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Virtual Reality Sickness Questionnaire
This questionnaire assess virtual reality sickness. This questionnaire consists of 2 subtitles as oculomotor and disorientation. It contains 9 symptoms in total. Each symptom is scored between 0 and 3 with the Likert type scoring system. Each subtitle adapted to be calculated by dividing the total score to a score system in itself like person receives%. The total score of the questionnaire will be obtained by averaging the total scores of the two subtitles.
Change from Baseline sickness after 1 hour later.
graybiel scale
This questionnaire assess virtual reality sickness. Total score ranges from 0-50. 0-2 points are interpreted as "light susceptibility to motion sickness", 3-7 points as "moderate susceptibility to motion sickness", 8-15 points as "extreme susceptibility to motion sickness", and values above 16 are "Definitive motion sickness".
Change from Baseline sickness after 1 hour later.
Secondary Outcomes (2)
international physical activity questionnaire
All of the participants will assess at baseline with this scale.
tampa kinesiophobia scale
All of the participants will assess at baseline with this scale.
Eligibility Criteria
Healthy people
You may qualify if:
- Not having mental - cognitive problems,
- Being a volunteer
You may not qualify if:
- Oculomotor and vestibular disease
- Cardiovascular, neurological and gastrointestinal problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hatice Çetin
Ankara, Sıhhiye, 06100, Turkey (Türkiye)
Related Publications (1)
Kim HK, Park J, Choi Y, Choe M. Virtual reality sickness questionnaire (VRSQ): Motion sickness measurement index in a virtual reality environment. Appl Ergon. 2018 May;69:66-73. doi: 10.1016/j.apergo.2017.12.016. Epub 2018 Jan 16.
PMID: 29477332BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
NEZİRE KOSE
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assisstant
Study Record Dates
First Submitted
July 20, 2020
First Posted
July 23, 2020
Study Start
June 30, 2021
Primary Completion
January 30, 2023
Study Completion
March 30, 2023
Last Updated
April 18, 2023
Record last verified: 2023-04